Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 144
Filtrar
Más filtros

Base de datos
Tipo del documento
Intervalo de año de publicación
1.
Mol Brain ; 14(1): 139, 2021 09 10.
Artículo en Inglés | MEDLINE | ID: mdl-34507588

RESUMEN

Chronic pain easily leads to concomitant mood disorders, and the excitability of anterior cingulate cortex (ACC) pyramidal neurons (PNs) is involved in chronic pain-related anxiety. However, the mechanism by which PNs regulate pain-related anxiety is still unknown. The GABAergic system plays an important role in modulating neuronal activity. In this paper, we aimed to study how the GABAergic system participates in regulating the excitability of ACC PNs, consequently affecting chronic inflammatory pain-related anxiety. A rat model of CFA-induced chronic inflammatory pain displayed anxiety-like behaviors, increased the excitability of ACC PNs, and reduced inhibitory presynaptic transmission; however, the number of GAD65/67 was not altered. Interestingly, intra-ACC injection of the GABAAR agonist muscimol relieved anxiety-like behaviors but had no effect on chronic inflammatory pain. Intra-ACC injection of the GABAAR antagonist picrotoxin induced anxiety-like behaviors but had no effect on pain in normal rats. Notably, chemogenetic activation of GABAergic neurons in the ACC alleviated chronic inflammatory pain and pain-induced anxiety-like behaviors, enhanced inhibitory presynaptic transmission, and reduced the excitability of ACC PNs. Chemogenetic inhibition of GABAergic neurons in the ACC led to pain-induced anxiety-like behaviors, reduced inhibitory presynaptic transmission, and enhanced the excitability of ACC PNs but had no effect on pain in normal rats. We demonstrate that the GABAergic system mediates a reduction in inhibitory presynaptic transmission in the ACC, which leads to enhanced excitability of pyramidal neurons in the ACC and is associated with chronic inflammatory pain-related anxiety.


Asunto(s)
Ansiedad/fisiopatología , Dolor Crónico/fisiopatología , Neuronas GABAérgicas/fisiología , Giro del Cíngulo/fisiopatología , Inflamación/psicología , Células Piramidales/fisiología , Animales , Ansiolíticos/administración & dosificación , Ansiolíticos/farmacología , Ansiolíticos/uso terapéutico , Ansiedad/tratamiento farmacológico , Ansiedad/etiología , Sensibilización del Sistema Nervioso Central/efectos de los fármacos , Dolor Crónico/psicología , Clozapina/uso terapéutico , Adyuvante de Freund/toxicidad , Agonistas de Receptores de GABA-A/administración & dosificación , Agonistas de Receptores de GABA-A/farmacología , Agonistas de Receptores de GABA-A/uso terapéutico , Antagonistas de Receptores de GABA-A/administración & dosificación , Antagonistas de Receptores de GABA-A/farmacología , Antagonistas de Receptores de GABA-A/toxicidad , Neuronas GABAérgicas/enzimología , Vectores Genéticos/farmacología , Inflamación/inducido químicamente , Inflamación/fisiopatología , Inyecciones , Interneuronas/efectos de los fármacos , Masculino , Muscimol/administración & dosificación , Muscimol/farmacología , Muscimol/uso terapéutico , Prueba de Campo Abierto , Umbral del Dolor/efectos de los fármacos , Técnicas de Placa-Clamp , Picrotoxina/toxicidad , Terminales Presinápticos/efectos de los fármacos , Terminales Presinápticos/fisiología , Células Piramidales/enzimología , Ratas , Ratas Sprague-Dawley
2.
Neural Plast ; 2021: 5566890, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34257639

RESUMEN

A number of currently used drugs have been obtained from medicinal plants which are a major source of drugs. These drugs are either used in their pure form or modified to a semisynthetic drug. Drug discovery through natural product research has been fruitful over the years. Traditionally, Calotropis procera is used extensively in the management of epilepsy. This study is conducted to explore the anticonvulsant effect of a hydroethanolic leaf extract of Calotropis procera (CPE) in murine models. This effect was evaluated using picrotoxin-induced convulsions, strychnine-induced convulsions, and isoniazid- and pilocarpine-induced status epilepticus in mice of both sexes. The results showed that CPE (100-300 mg/kg) exhibited an anticonvulsant effect against strychnine-induced clonic seizures by significantly reducing the duration (p = 0.0068) and frequency (p = 0.0016) of convulsions. The extract (100-300 mg/kg) caused a profound dose-dependent delay in the onset of clonic convulsions induced by picrotoxin (p < 0.0001) and tonic convulsions (p < 0.0001) in mice. The duration of convulsions was reduced significantly also for both clonic and tonic (p < 0.0001) seizures as well. CPE (100-300 mg/kg), showed a profound anticonvulsant effect and reduced mortality in the pilocarpine-induced convulsions. ED50 (~0.1007) determined demonstrated that the extract was less potent than diazepam in reducing the duration and onset of convulsions but had comparable efficacies. Flumazenil-a GABAA receptor antagonist-did not reverse the onset or duration of convulsions produced by the extract in the picrotoxin-induced seizure model. In isoniazid-induced seizure, CPE (300 mg kg1, p.o.) significantly (p < 0.001) delayed the onset of seizure in mice and prolonged latency to death in animals. Overall, the hydroethanolic leaf extract of Calotropis procera possesses anticonvulsant properties.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Calotropis/química , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Convulsiones/tratamiento farmacológico , Estado Epiléptico/tratamiento farmacológico , Animales , Anticonvulsivantes/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Convulsivantes/toxicidad , Diazepam/uso terapéutico , Evaluación Preclínica de Medicamentos , Etanol , Femenino , Flumazenil/uso terapéutico , Isoniazida/toxicidad , Masculino , Ratones , Ratones Endogámicos ICR , Fitoterapia , Picrotoxina/toxicidad , Pilocarpina/toxicidad , Extractos Vegetales/aislamiento & purificación , Receptores de GABA-A/fisiología , Convulsiones/inducido químicamente , Solventes , Estricnina/toxicidad , Agua
3.
Neurol India ; 69(2): 426-429, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33904467

RESUMEN

INTRODUCTION: Epilepsy is a common neurological disease, although its etiology and pathophysiology are not yet fully understood. Oxidative stress plays a key role in the pathogenesis of many neurological diseases, including epilepsy, and there have been many studies reporting that antiepileptic medicines with neuroprotective and antioxidant activity inhibit free oxygen radicals. This study evaluates the effects of tempol on epileptic activity through behavioral parameters in acute picrotoxin (Ptx) models. MATERIALS AND METHODS: This experimental study was conducted on 42 adult male Wistar Albino rats weighing 450-500 g. Ptx (2.5 mg/kg) was injected i.p. as a single dose and observed for one hour to establish the acute Ptx model. Following injection, the animals were observed for 30 min in glass observation cages measuring 35 cm x 35 cm x 35 cm. RESULTS: In picrotoxin-induced epilepsy, the total number of seizures and the total duration of seizures were decreased significantly with Ptx + tempol 100 mg/kg and Ptx + Tempol 150 mg/kg. The seizure phases were reduced significantly by Ptx + tempol 150 mg/kg (P < 0.05). CONCLUSION: Tempol 100 mg/kg and tempol 150 mg/kg are found to be effective in epilepsy models caused by Ptx, with tempol 150 mg/kg found especially to be more effective.


Asunto(s)
Epilepsia , Animales , Óxidos N-Cíclicos , Modelos Animales de Enfermedad , Epilepsia/inducido químicamente , Epilepsia/tratamiento farmacológico , Masculino , Picrotoxina/toxicidad , Ratas , Ratas Wistar , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Marcadores de Spin
4.
J Ethnopharmacol ; 272: 113955, 2021 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-33610704

RESUMEN

ETHNOPHARMACOLOGY RELEVANCE: The decoction from the stem bark of Psychotria camptopus (Rubiaceae) is used in the Cameroonian pharmacopoeia to treat neurological pathologies including epilepsy. AIM: The present work was undertaken to study the anticonvulsant properties of the aqueous (AE) and methanol (ME) extracts from the stem bark of P. camptopus in acute models of epileptic seizures in Wistar rats. METHOD: AE and ME were obtained by decoction and maceration of the stem bark powder in water and methanol, respectively. They were tested orally at the doses of 40, 80 and 120 mg/kg, on the latency of onset and duration of epileptic seizures induced by pentylene tetrazole (PTZ, 70 mg/kg, i.p.). The kinetic effect of both extracts at 120 mg/kg was evaluated. Their effects on diazepam (50 mg/kg) induced sleep and strychnine (STR, 2.5 mg/kg, i.p.) induced seizures were determined. ME was further tested on picrotoxin (PIC, 7.5 mg/kg, i.p.) and thiosemicarbazide (TSC, 50 mg/kg, i.p.) induced seizure models. The phytochemical composition of ME was assessed using LC-MS method, as well as its acute toxicity. RESULTS: AE and ME significantly (p < 0.001) reduced the duration of seizures in both PTZ and STR models. Their maximal effect was observed at 1 h after administration, though their effect at 120 mg/kg was maintained (p < 0.05) up to 24 h post-treatment. Both extracts significantly (p < 0.01) reduced sleep duration. ME significantly (p < 0.001) increased the latency of rat death on PIC-induced convulsions. In TSC rats, ME significantly (p < 0.001) delayed the latency to the first convulsion, and decreased the duration and frequency of convulsions. ME showed no acute toxicity while its phytochemical screening revealed the presence of two flavonoids (Rutin and Butin), two triterpenoid saponins (Psycotrianoside B and Bauerenone) and four alkaloids (10-Hydroxy-antirhine, 10-hydroxy-iso-deppeaninol, Emetine and Hodkinsine). In conclusion, AE and ME from the stem bark of P. camptopus have comparable anticonvulsant properties. The effect of ME is likely due to the presence of flavonoids and alkaloid and the activation of GABA pathway. These results further justify and support the use of P. camptopus in traditional medicine for the treatment of epilepsy.


Asunto(s)
Anticonvulsivantes/farmacología , Epilepsia/tratamiento farmacológico , Extractos Vegetales/farmacología , Psychotria/química , Convulsiones/tratamiento farmacológico , Animales , Anticonvulsivantes/uso terapéutico , Anticonvulsivantes/toxicidad , Conducta Animal/efectos de los fármacos , Diazepam/farmacología , Diazepam/uso terapéutico , Modelos Animales de Enfermedad , Epilepsia/inducido químicamente , Metanol/química , Ratones , Pentilenotetrazol/toxicidad , Fitoquímicos/química , Fitoquímicos/farmacología , Fitoquímicos/uso terapéutico , Picrotoxina/toxicidad , Corteza de la Planta/química , Extractos Vegetales/uso terapéutico , Extractos Vegetales/toxicidad , Tallos de la Planta/química , Ratas Wistar , Convulsiones/inducido químicamente , Semicarbacidas/toxicidad , Sueño/efectos de los fármacos , Latencia del Sueño/efectos de los fármacos , Estricnina/toxicidad , Agua/química
5.
Arch Toxicol ; 94(6): 1995-2007, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32239239

RESUMEN

Acute intoxication with picrotoxin or the rodenticide tetramethylenedisulfotetramine (TETS) can cause seizures that rapidly progress to status epilepticus and death. Both compounds inhibit γ-aminobutyric acid type-A (GABAA) receptors with similar potency. However, TETS is approximately 100 × more lethal than picrotoxin. Here, we directly compared the toxicokinetics of the two compounds following intraperitoneal administration in mice. Using LC/MS analysis we found that picrotoxinin, the active component of picrotoxin, hydrolyses quickly into picrotoxic acid, has a short in vivo half-life, and is moderately brain penetrant (brain/plasma ratio 0.3). TETS, in contrast, is not metabolized by liver microsomes and persists in the body following intoxication. Using both GC/MS and a TETS-selective immunoassay we found that mice administered TETS at the LD50 of 0.2 mg/kg in the presence of rescue medications exhibited serum levels that remained constant around 1.6 µM for 48 h before falling slowly over the next 10 days. TETS showed a similar persistence in tissues. Whole-cell patch-clamp demonstrated that brain and serum extracts prepared from mice at 2 and 14 days after TETS administration significantly blocked heterologously expressed α2ß3γ2 GABAA-receptors confirming that TETS remains pharmacodynamically active in vivo. This observed persistence may contribute to the long-lasting and recurrent seizures observed following human exposures. We suggest that countermeasures to neutralize TETS or accelerate its elimination should be explored for this highly dangerous threat agent.


Asunto(s)
Encéfalo/efectos de los fármacos , Hidrocarburos Aromáticos con Puentes/toxicidad , Convulsivantes/toxicidad , Antagonistas del GABA/toxicidad , Picrotoxina/análogos & derivados , Convulsiones/inducido químicamente , Animales , Biotransformación , Encéfalo/metabolismo , Encéfalo/fisiopatología , Hidrocarburos Aromáticos con Puentes/farmacocinética , Convulsivantes/farmacocinética , Antagonistas del GABA/farmacocinética , Dosificación Letal Mediana , Masculino , Ratones , Picrotoxina/farmacocinética , Picrotoxina/toxicidad , Receptores de GABA-A/metabolismo , Convulsiones/metabolismo , Convulsiones/fisiopatología , Sesterterpenos , Distribución Tisular , Toxicocinética
6.
Cent Nerv Syst Agents Med Chem ; 20(2): 144-154, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32072918

RESUMEN

OBJECTIVE: To determine the potential effect of Pyrenancantha staudtii extract on experimentally induced seizures in mice and to evaluate the role of benzodiazepines, naloxone, and serotonin within these pathways. METHODS: Animal behaviours were evaluated using open field, hexobarbitone-induced sleep model, and anticonvulsant activity using picrotoxin-, or strychnine-, or isoniazid-induced convulsions. Attempt to understand the mode of action of the anticonvulsant activity of the plant, three notable antagonists (flumazenil, 3 mg/kg; naloxone 5 mg/kg, i.p., and cyproheptadine, 4 mg/kg, i.p) were used. RESULTS: The results revealed a significant (p < 0.05) reduction in the frequency of rearing and grooming episodes compared with the control. The extract of P. staudtii potentiates the sleeping time of hexobarbitone-induced hypnosis in a dose-related manner. P. staudtii stem bark extracts significantly (p<0.05) prolonged the onset of a seizure and attenuated the duration of seizure in a dose-dependent manner in picrotoxin- and or isoniazid-induced seizures. While, P. staudtii stem bark extract at all doses (100, 200, and 400 mg kg-1) though significantly prolonged the onset of action, but did not confer any significant changes on the duration, as well as mortality in this strychnine-induced seizure model. However, the anticonvulsant activity of the methanolic extract of P. staudtii was significantly reversed following intraperitoneal pre-treatment with flumazenil (GABA receptor antagonist) and naloxone (opioid receptor antagonist) but not cyproheptadine (5-HT2 receptor antagonist) in picrotoxin-induced convulsion. CONCLUSION: The data obtained suggest that methanol extract of P. staudtii possessed significant anticonvulsant effect, thereby confirming the traditional uses of P. staudtii in the treatment of epilepsy; mechanisms of which could involve the interaction with GABAergic and or opioidergic system.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Metanol/uso terapéutico , Extractos Vegetales/uso terapéutico , Plantas Medicinales , Convulsiones/tratamiento farmacológico , Animales , Anticonvulsivantes/química , Anticonvulsivantes/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Masculino , Metanol/química , Ratones , Picrotoxina/toxicidad , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Convulsiones/inducido químicamente , Convulsiones/fisiopatología , Pruebas de Toxicidad Aguda/métodos
7.
Neurotoxicology ; 76: 220-234, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31811871

RESUMEN

Previous studies demonstrated that pentylenetetrazole (PTZ), a GABA type A receptor (GABAAR) antagonist, elicits seizure-like phenotypes in larval zebrafish (Danio rerio). Here, we determined whether the GABAAR antagonists, tetramethylenedisulfotetramine (TETS) and picrotoxin (PTX), both listed as credible chemical threat agents, similarly trigger seizures in zebrafish larvae. Larvae of three, routinely used laboratory zebrafish lines, Tropical 5D, NHGRI and Tupfel long fin, were exposed to varying concentrations of PTZ (used as a positive control), PTX or TETS for 20 min at 5 days post fertilization (dpf). Acute exposure to PTZ, PTX or TETS triggered seizure behavior in the absence of morbidity or mortality. While the concentration-effect relationship for seizure behavior was similar across zebrafish lines for each GABAAR antagonist, significantly less TETS was required to trigger seizures relative to PTX or PTZ. Recordings of extracellular field potentials in the optic tectum of 5 dpf Tropical 5D zebrafish confirmed that all three GABAAR antagonists elicited extracellular spiking patterns consistent with seizure activity, although the pattern varied between chemicals. Post-exposure treatment with the GABAAR positive allosteric modulators (PAMs), diazepam, midazolam or allopregnanolone, attenuated seizure behavior and activity but did not completely normalize electrical field recordings in the optic tectum. These data are consistent with observations of seizure responses in mammalian models exposed to these same GABAAR antagonists and PAMs, further validating larval zebrafish as a higher throughput-screening platform for antiseizure therapeutics, and demonstrating its appropriateness for identifying improved countermeasures for TETS and other convulsant chemical threat agents that trigger seizures via GABAAR antagonism.


Asunto(s)
Encéfalo/efectos de los fármacos , Evaluación Preclínica de Medicamentos/métodos , Antagonistas de Receptores de GABA-A/toxicidad , Convulsiones/inducido químicamente , Animales , Encéfalo/fisiopatología , Hidrocarburos Aromáticos con Puentes/toxicidad , Pentilenotetrazol/toxicidad , Picrotoxina/toxicidad , Convulsiones/fisiopatología , Pez Cebra
8.
J Neuroinflammation ; 16(1): 66, 2019 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-30922332

RESUMEN

BACKGROUND: Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1ß secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1ß and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. METHODS: In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. RESULTS: Our results demonstrated that IL-10 inhibits IL-1ß production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1ß maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1ß. CONCLUSIONS: Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.


Asunto(s)
Interleucina-10/farmacología , Interleucina-1beta/metabolismo , Microglía/metabolismo , Convulsiones/patología , Animales , Encéfalo/patología , Células Cultivadas , Convulsivantes/toxicidad , Citocinas/genética , Citocinas/metabolismo , Modelos Animales de Enfermedad , Regulación de la Expresión Génica/efectos de los fármacos , Lipopolisacáridos/toxicidad , Masculino , Ratones , Ratones Endogámicos C57BL , Microglía/efectos de los fármacos , Ácidos Nucleicos/genética , Ácidos Nucleicos/metabolismo , Picrotoxina/toxicidad , ARN Interferente Pequeño/farmacología , Factor de Transcripción STAT3/metabolismo , Convulsiones/inducido químicamente , Convulsiones/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética
9.
Neurotoxicology ; 67: 215-225, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29909083

RESUMEN

Neurotoxicity testing still relies on ethically debated, expensive and time consuming in vivo experiments, which are unsuitable for high-throughput toxicity screening. There is thus a clear need for a rapid in vitro screening strategy that is preferably based on human-derived neurons to circumvent interspecies translation. Recent availability of commercially obtainable human induced pluripotent stem cell (hiPSC)-derived neurons and astrocytes holds great promise in assisting the transition from the current standard of rat primary cortical cultures to an animal-free alternative. We therefore composed several hiPSC-derived neuronal models with different ratios of excitatory and inhibitory neurons in the presence or absence of astrocytes. Using immunofluorescent stainings and multi-well micro-electrode array (mwMEA) recordings we demonstrate that these models form functional neuronal networks that become spontaneously active. The differences in development of spontaneous neuronal activity and bursting behavior as well as spiking patterns between our models confirm the importance of the presence of astrocytes. Preliminary neurotoxicity assessment demonstrates that these cultures can be modulated with known seizurogenic compounds, such as picrotoxin (PTX) and endosulfan, and the neurotoxicant methylmercury (MeHg). However, the chemical-induced effects on different parameters for neuronal activity, such as mean spike rate (MSR) and mean burst rate (MBR), may depend on the ratio of inhibitory and excitatory neurons. Our results thus indicate that hiPSC-derived neuronal models must be carefully designed and characterized prior to large-scale use in neurotoxicity screening.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Astrocitos/efectos de los fármacos , Células Madre Pluripotentes Inducidas/fisiología , Neuronas/efectos de los fármacos , Potenciales de Acción/fisiología , Astrocitos/fisiología , Células Cultivadas , Técnicas de Cocultivo/métodos , Endosulfano/toxicidad , Humanos , Células Madre Pluripotentes Inducidas/efectos de los fármacos , Compuestos de Metilmercurio/toxicidad , Neuronas/fisiología , Picrotoxina/toxicidad
10.
J Neuroimmunol ; 298: 32-41, 2016 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-27609273

RESUMEN

Experimental autoimmune encephalomyelitis (EAE) is a common rodent model for multiple sclerosis (MS). Yet, the long-term consequences for retina and optic nerve (ON) are unknown. C57BL/6 mice were immunized with an encephalitogenic peptide (MOG35-55) and the controls received the carriers or PBS. Clinical symptoms started at day 8, peaked at day 14, and were prevalent until day 60. They correlated with infiltration and demyelination of the ON. In MOG-immunized animals more microglia cells in the ONs and retinas were detected at day 60. Additionally, retinal ganglion cell (RGC) loss was combined with an increased macroglia response. At this late stage, an increased number of microglia was associated with axonal damage in the ON and in the retina with RGC loss. Whether glial activation contributes to repair mechanisms or adversely affects the number of RGCs is currently unclear.


Asunto(s)
Encefalomielitis Autoinmune Experimental/patología , Microglía/fisiología , Nervio Óptico/patología , Retina/patología , Análisis de Varianza , Animales , Axones/efectos de los fármacos , Axones/patología , Proteínas de Unión al Calcio/metabolismo , Estimulantes del Sistema Nervioso Central/toxicidad , Modelos Animales de Enfermedad , Encefalomielitis Autoinmune Experimental/inducido químicamente , Adyuvante de Freund/toxicidad , Proteína Ácida Fibrilar de la Glía/metabolismo , Ratones , Ratones Endogámicos C57BL , Proteínas de Microfilamentos/metabolismo , Microglía/efectos de los fármacos , Glicoproteína Mielina-Oligodendrócito/toxicidad , Nervio Óptico/efectos de los fármacos , Fragmentos de Péptidos/toxicidad , Picrotoxina/toxicidad , Proteína Quinasa C-alfa/metabolismo , Retina/efectos de los fármacos , Factor de Transcripción Brn-3A/metabolismo , Vimentina/metabolismo
11.
Cell Physiol Biochem ; 35(4): 1633-42, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25824461

RESUMEN

BACKGROUND: Homer is a family of post synaptic density proteins functionally and physically attached to target proteins at proline-rich sequences. Reducing Homer1b/c expression has been shown in previous studies to be protective against excitotoxic insults, implicating Homer1b/c in the physiological regulation of aberrant neuronal excitability. METHODS: To test the efficacy of a Homer1b/c reducing therapy for disorders with a detrimental hyperexcitability profile in mice, we used small interfere RNA (siRNA) to decrease endogenous Homer1b/c expression in mouse hippocampus. The baseline motor and cognitive behavior was measured by sensorimotor tests, Morris water maze and elevated plus maze tasks. The anti-epileptic effects of Homer1b/c knockdown were determined in two chemically induced seizure models induced by Picrotoxin (PTX) or pentylenetetrazole (PTZ) administration. RESULTS: The results of sensorimotor tests, Morris water maze and elevated plus maze tasks showed that Homer1b/c reduction had no effect on baseline motor or cognitive behavior. In two chemically induced seizure models, mice with reduced Homerb/c protein had less severe seizures than control mice. Total Homer1b/c protein levels and seizure severity were highly correlated, such that those mice with the most severe seizures also had the highest levels of Homer1b/c. In addition, the phosphorylation of mammalian target of rapamycin (mTOR) and its target protein S6 was significantly inhibited in Homer1b/c down-regulated mice. Homer1b/c knockdown-induced inhibition of mTOR pathway was partially ablated by the metabotropic glutamate receptor 5 (mGluR5) agonist CHPG. CONCLUSION: Our results demonstrate that endogenous Homer1b/c is integral for regulating neuronal hyperexcitability in adult animals and suggest that reduction of Homer1b/c could protect against chemically induced seizures through inhibition mTOR pathway.


Asunto(s)
Proteínas Portadoras/metabolismo , Serina-Treonina Quinasas TOR/metabolismo , Animales , Conducta Animal , Proteínas Portadoras/antagonistas & inhibidores , Proteínas Portadoras/genética , Modelos Animales de Enfermedad , Regulación hacia Abajo/efectos de los fármacos , Glicina/análogos & derivados , Glicina/farmacología , Hipocampo/metabolismo , Proteínas de Andamiaje Homer , Aprendizaje por Laberinto , Ratones , Células PC12 , Pentilenotetrazol/toxicidad , Fenilacetatos/farmacología , Fosforilación , Picrotoxina/toxicidad , Interferencia de ARN , Ratas , Receptor del Glutamato Metabotropico 5/agonistas , Receptor del Glutamato Metabotropico 5/metabolismo , Proteínas Quinasas S6 Ribosómicas/metabolismo , Convulsiones/inducido químicamente , Convulsiones/metabolismo , Convulsiones/patología , Transducción de Señal/efectos de los fármacos , Serina-Treonina Quinasas TOR/antagonistas & inhibidores
12.
Exp Neurol ; 265: 122-8, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25597650

RESUMEN

The pathophysiology of the tics that define Gilles de la Tourette syndrome (TS) is not well understood. Local disinhibition within the striatum has been hypothesized to play a pathogenic role. In support of this, experimental disinhibition by local antagonism of GABA-A receptors within the striatum produces tic-like phenomenology in monkey and rat. We replicated this effect in mice via local picrotoxin infusion into the dorsal striatum. Infusion of picrotoxin into sensorimotor cortex produced similar movements, accompanied by signs of behavioral activation; higher-dose picrotoxin in the cortex produced seizures. Striatal inhibition with local muscimol completely abolished tic-like movements after either striatal or cortical picrotoxin, confirming their dependence on the striatal circuitry; in contrast, cortical muscimol attenuated but did not abolish movements produced by striatal picrotoxin. Striatal glutamate blockade eliminated tic-like movements after striatal picrotoxin, indicating that glutamatergic afferents are critical for their generation. These studies replicate and extend previous work in monkey and rat, providing additional validation for the local disinhibition model of tic generation. Our results reveal a key role for corticostriatal glutamatergic afferents in the generation of tic-like movements in this model.


Asunto(s)
Cuerpo Estriado/fisiopatología , Inhibición Neural , Corteza Sensoriomotora/fisiopatología , Tics/fisiopatología , Animales , Cuerpo Estriado/efectos de los fármacos , Electroencefalografía/efectos de los fármacos , Electroencefalografía/métodos , Masculino , Ratones , Ratones Endogámicos C57BL , Inhibición Neural/efectos de los fármacos , Inhibición Neural/fisiología , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/fisiopatología , Picrotoxina/toxicidad , Corteza Sensoriomotora/efectos de los fármacos , Tics/inducido químicamente
13.
Bull Exp Biol Med ; 157(6): 742-6, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25339590

RESUMEN

Anticonvulsant activity and pharmacokinetics of nanoemulsion and unmodified substance of carbamazepine were compared in experiments on mice. Carbamazepine nanoemulsion demonstrated significant anticonvulsant activity and was superior to unmodified substance of carbamazepine against seizures induced by maximum electric shock and picrotoxin. Relative bioavailability of carbamazepine after administration of nanoemulsion was 160% compared to unmodified substance. Carbamazepine nanoemulsion more effectively penetrated through BBB by 1.5 times in comparison with unmodified substance.


Asunto(s)
Anticonvulsivantes/farmacología , Anticonvulsivantes/farmacocinética , Dietilcarbamazina/farmacología , Dietilcarbamazina/farmacocinética , Emulsiones/farmacología , Emulsiones/farmacocinética , Convulsiones/tratamiento farmacológico , Animales , Disponibilidad Biológica , Barrera Hematoencefálica/metabolismo , Dietilcarbamazina/administración & dosificación , Estimulación Eléctrica , Emulsiones/administración & dosificación , Masculino , Ratones , Nanoestructuras/administración & dosificación , Picrotoxina/toxicidad , Convulsiones/inducido químicamente , Estadísticas no Paramétricas
14.
Int J Mol Sci ; 15(9): 16500-10, 2014 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-25238414

RESUMEN

Four new pentacyclic benzodiazepine derivatives (PBDTs 13-16) were synthesized by conventional thermal heating and microwave-assisted intramolecular cyclocondensation. Their anticonvulsant, sedative and anxiolytic activities were evaluated by drug-induced convulsion models, a pentobarbital-induced hypnotic model and an elevated plus maze in mice. PBDT 13, a triazolopyrrolo[2,1-c][1,4]benzodiazepin-8-one fused with a thiadiazolone ring, exhibited the best anticonvulsant, sedative and anxiolytic effects in our tests. There was no significant difference in potency between PBDT 13 and diazepam, and we proposed that the action mechanism of PBDT 13 could be similar to that of diazepam via benzodiazepine receptors.


Asunto(s)
Ansiolíticos/síntesis química , Anticonvulsivantes/síntesis química , Benzodiazepinonas/síntesis química , Compuestos Heterocíclicos de 4 o más Anillos/síntesis química , Hipnóticos y Sedantes/síntesis química , Animales , Ansiolíticos/farmacología , Ansiolíticos/uso terapéutico , Anticonvulsivantes/farmacología , Anticonvulsivantes/uso terapéutico , Benzodiazepinonas/farmacología , Benzodiazepinonas/uso terapéutico , Conducta Exploratoria/efectos de los fármacos , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Compuestos Heterocíclicos de 4 o más Anillos/uso terapéutico , Hipnóticos y Sedantes/farmacología , Hipnóticos y Sedantes/uso terapéutico , Masculino , Ratones , Ratones Endogámicos ICR , Estructura Molecular , Pentobarbital/toxicidad , Picrotoxina/toxicidad , Reflejo Anormal/efectos de los fármacos , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Estricnina/toxicidad
15.
J Neurosci ; 33(31): 12887-97, 2013 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-23904623

RESUMEN

Tau, a microtubule-associated protein, is implicated in the pathogenesis of Alzheimer's Disease (AD) in regard to both neurofibrillary tangle formation and neuronal network hyperexcitability. The genetic ablation of tau substantially reduces hyperexcitability in AD mouse lines, induced seizure models, and genetic in vivo models of epilepsy. These data demonstrate that tau is an important regulator of network excitability. However, developmental compensation in the genetic tau knock-out line may account for the protective effect against seizures. To test the efficacy of a tau reducing therapy for disorders with a detrimental hyperexcitability profile in adult animals, we identified antisense oligonucleotides that selectively decrease endogenous tau expression throughout the entire mouse CNS--brain and spinal cord tissue, interstitial fluid, and CSF--while having no effect on baseline motor or cognitive behavior. In two chemically induced seizure models, mice with reduced tau protein had less severe seizures than control mice. Total tau protein levels and seizure severity were highly correlated, such that those mice with the most severe seizures also had the highest levels of tau. Our results demonstrate that endogenous tau is integral for regulating neuronal hyperexcitability in adult animals and suggest that an antisense oligonucleotide reduction of tau could benefit those with epilepsy and perhaps other disorders associated with tau-mediated neuronal hyperexcitability.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Oligonucleótidos Antisentido/uso terapéutico , Convulsiones/prevención & control , Proteínas tau/genética , Factores de Edad , Animales , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/metabolismo , Convulsivantes/toxicidad , Modelos Animales de Enfermedad , Trastornos Neurológicos de la Marcha/tratamiento farmacológico , Trastornos Neurológicos de la Marcha/etiología , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Infusiones Intraventriculares , Ácido Láctico/metabolismo , Locomoción/genética , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microdiálisis , Pentilenotetrazol/toxicidad , Picrotoxina/toxicidad , Convulsiones/inducido químicamente , Convulsiones/genética , Proteínas tau/química , Proteínas tau/metabolismo
16.
Eur Rev Med Pharmacol Sci ; 17(16): 2141-4, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23893179

RESUMEN

OBJECTIVES: Hypericum (H.) spp. has been used in traditional medicine for their anticonvulsant effect for many years. In spite of many works on this genus, little is known about H. scabrum. In this work, anticonvulsant activity of H. scabrum was investigated. MATERIALS AND METHODS: Anticonvulsant activity of aqueous extract was evaluated by pentylenetetrazole (PTZ) induced convulsion and picrotoxin induced convulsion. Also, nitric oxide radical scavenging was investigated as a possible mechanism involved. RESULTS: Extract (125-500 mg kg-1, i.p.) significantly delayed the onset of PTZ induced convulsion. At 500 mg kg-1, 100% protection against mortality was observed. At this dose, it significantly prolonged the onset of picrotoxin induced convulsion in mice, too. It showed significant nitric oxide radical scavenging activity. CONCLUSIONS: Mechanism of anticonvulsant activity may be through GABA and/or nitric oxide pathway.


Asunto(s)
Anticonvulsivantes/farmacología , Hypericum/química , Extractos Vegetales/farmacología , Convulsiones/tratamiento farmacológico , Animales , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/aislamiento & purificación , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Depuradores de Radicales Libres/administración & dosificación , Depuradores de Radicales Libres/aislamiento & purificación , Depuradores de Radicales Libres/farmacología , Masculino , Medicina Tradicional , Ratones , Óxido Nítrico/metabolismo , Pentilenotetrazol/toxicidad , Picrotoxina/toxicidad , Extractos Vegetales/administración & dosificación , Convulsiones/fisiopatología , Factores de Tiempo , Ácido gamma-Aminobutírico/metabolismo
17.
Neuropharmacology ; 73: 425-31, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23774136

RESUMEN

The lung provides a portal of entry that could be used to rapidly deliver anticonvulsant substances to the brain to treat seizures. In the present study, we demonstrate that midazolam, a water-soluble anticonvulsant benzodiazepine, confers potent seizure protection when administered via the intrapulmonary route. High dose (100 mg/kg) intraperitoneal midazolam induced loss-of-righting reflex in mice. Lower doses of midazolam (100-1000 µg/kg) when administered intraperitoneally did not induce loss-of-righting reflex but protected animals against pentylenetetrazol (PTZ)-induced seizures. Intrapulmonary administration of midazolam via a tracheal cannula protected against intraperitoneal PTZ seizures at lower doses. The minimal intraperitoneal and intravenous doses of midazolam required to elevate the threshold for seizure signs induced by intravenous PTZ were 500 and 100 µg/kg, respectively, whereas the minimal intrapulmonary midazolam dose was 12.5 µg/kg. Intratracheal midazolam caused a large increase in intravenous PTZ threshold 5 min after administration but the effect declined rapidly over 60 min and no antiseizure activity was evident at 120 min. The minimal intraperitoneal doses of midazolam required to elevate the threshold for seizure signs induced by intravenous picrotoxin and kainic acid were 100 and 2000 µg/kg, respectively; the corresponding values for intratracheal midazolam were 25 and 100 µg/kg, respectively. We conclude that midazolam is a highly effective anticonvulsant when administered by the intrapulmonary route. Midazolam is substantially more potent when delivered into the lung than when administered intraperitoneally or intravenously. Inhalation could be an alternative to other routes of administration for the delivery of midazolam to rapidly abort acute seizures.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Midazolam/uso terapéutico , Convulsiones/prevención & control , Animales , Anticonvulsivantes/administración & dosificación , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Ácido Kaínico/toxicidad , Masculino , Ratones , Midazolam/administración & dosificación , Pentilenotetrazol , Picrotoxina/toxicidad , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico
18.
Pract Neurol ; 13(3): 185-7, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23487821
19.
Toxicol Sci ; 130(2): 362-72, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22889812

RESUMEN

Tetramethylenedisulfotetramine (TETS) is a potent convulsant that is considered a chemical threat agent. We characterized TETS as an activator of spontaneous Ca²âº oscillations and electrical burst discharges in mouse hippocampal neuronal cultures at 13-17 days in vitro using FLIPR Fluo-4 fluorescence measurements and extracellular microelectrode array recording. Acute exposure to TETS (≥ 2 µM) reversibly altered the pattern of spontaneous neuronal discharges, producing clustered burst firing and an overall increase in discharge frequency. TETS also dramatically affected Ca²âº dynamics causing an immediate but transient elevation of neuronal intracellular Ca²âº followed by decreased frequency of Ca²âº oscillations but greater peak amplitude. The effect on Ca²âº dynamics was similar to that elicited by picrotoxin and bicuculline, supporting the view that TETS acts by inhibiting type A gamma-aminobutyric acid (GABA(A)) receptor function. The effect of TETS on Ca²âº dynamics requires activation of N-methyl-D-aspartic acid (NMDA) receptors, because the changes induced by TETS were prevented by MK-801 block of NMDA receptors, but not nifedipine block of L-type Ca²âº channels. Pretreatment with the GABA(A) receptor-positive modulators diazepam and allopregnanolone partially mitigated TETS-induced changes in Ca²âº dynamics. Moreover, low, minimally effective concentrations of diazepam (0.1 µM) and allopregnanolone (0.1 µM), when administered together, were highly effective in suppressing TETS-induced alterations in Ca²âº dynamics, suggesting that the combination of positive modulators of synaptic and extrasynaptic GABA(A) receptors may have therapeutic potential. These rapid throughput in vitro assays may assist in the identification of single agents or combinations that have utility in the treatment of TETS intoxication.


Asunto(s)
Anticonvulsivantes/farmacología , Hidrocarburos Aromáticos con Puentes/toxicidad , Señalización del Calcio/efectos de los fármacos , Convulsivantes/toxicidad , Antagonistas de Aminoácidos Excitadores/toxicidad , Hipocampo/efectos de los fármacos , Neuronas/efectos de los fármacos , Receptores de GABA-A/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Potenciales de Acción , Animales , Animales Recién Nacidos , Bicuculina/toxicidad , Bloqueadores de los Canales de Calcio/farmacología , Células Cultivadas , Diazepam/farmacología , Maleato de Dizocilpina/toxicidad , Relación Dosis-Respuesta a Droga , Antagonistas de Receptores de GABA-A/toxicidad , Ensayos Analíticos de Alto Rendimiento/instrumentación , Ensayos Analíticos de Alto Rendimiento/métodos , Hipocampo/metabolismo , Ratones , Ratones Endogámicos C57BL , Microelectrodos , Neuronas/metabolismo , Picrotoxina/toxicidad , Pregnanolona/farmacología , Receptores de GABA-A/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Espectrometría de Fluorescencia , Factores de Tiempo
20.
Dis Model Mech ; 5(6): 773-84, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22730455

RESUMEN

The availability of animal models of epileptic seizures provides opportunities to identify novel anticonvulsants for the treatment of people with epilepsy. We found that exposure of 2-day-old zebrafish embryos to the convulsant agent pentylenetetrazole (PTZ) rapidly induces the expression of synaptic-activity-regulated genes in the CNS, and elicited vigorous episodes of calcium (Ca(2+)) flux in muscle cells as well as intense locomotor activity. We then screened a library of ∼2000 known bioactive small molecules and identified 46 compounds that suppressed PTZ-inducedtranscription of the synaptic-activity-regulated gene fos in 2-day-old (2 dpf) zebrafish embryos. Further analysis of a subset of these compounds, which included compounds with known and newly identified anticonvulsant properties, revealed that they exhibited concentration-dependent inhibition of both locomotor activity and PTZ-induced fos transcription, confirming their anticonvulsant characteristics. We conclude that this in situ hybridisation assay for fos transcription in the zebrafish embryonic CNS is a robust, high-throughput in vivo indicator of the neural response to convulsant treatment and lends itself well to chemical screening applications. Moreover, our results demonstrate that suppression of PTZ-induced fos expression provides a sensitive means of identifying compounds with anticonvulsant activities.


Asunto(s)
Anticonvulsivantes/análisis , Anticonvulsivantes/uso terapéutico , Modelos Animales de Enfermedad , Epilepsia/tratamiento farmacológico , Pez Cebra/fisiología , Animales , Anticonvulsivantes/farmacología , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/embriología , Sistema Nervioso Central/patología , Evaluación Preclínica de Medicamentos , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/patología , Epilepsia/genética , Epilepsia/patología , Epilepsia/fisiopatología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Hibridación in Situ , Larva/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Músculos/efectos de los fármacos , Músculos/embriología , Músculos/metabolismo , Músculos/patología , Especificidad de Órganos/efectos de los fármacos , Especificidad de Órganos/genética , Pentilenotetrazol , Picrotoxina/toxicidad , Bibliotecas de Moléculas Pequeñas/análisis , Bibliotecas de Moléculas Pequeñas/farmacología , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Pez Cebra/embriología , Pez Cebra/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA